Edition:
United Kingdom

Jounce Therapeutics Inc (JNCE.OQ)

JNCE.OQ on NASDAQ Stock Exchange Global Select Market

3.53USD
14 Dec 2018
Change (% chg)

$-0.16 (-4.34%)
Prev Close
$3.69
Open
$3.60
Day's High
$3.77
Day's Low
$3.50
Volume
55,379
Avg. Vol
77,120
52-wk High
$29.02
52-wk Low
$3.31

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 14.53 -0.234
Jun '18 19.38 -0.144
Mar '18 11.19 -0.402
FY 2017 Dec '17 12.99 -0.290
Sep '17 18.08 -0.127
Jun '17 20.29 -0.105
Mar '17 20.29 -0.017
FY 2016 Dec '16 20.29 0.076
Sep '16 16.91 0.004
Jun '16 0.00 -0.238
Mar '16 0.00 -6.811
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 6 12.63 15.00 9.90 62.83
Quarter Ending Mar-19 4 21.99 44.10 13.38 --
Year Ending Dec-18 6 57.70 60.00 55.00 117.64
Year Ending Dec-19 6 62.09 86.00 43.00 72.42
Earnings (per share)
Quarter Ending Dec-18 6 -0.34 -0.25 -0.46 2.50
Quarter Ending Mar-19 4 -0.07 0.63 -0.33 --
Year Ending Dec-18 6 -1.13 -1.03 -1.24 -0.11
Year Ending Dec-19 6 -1.29 -0.25 -2.33 -2.33
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 7,903.67 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) 7.13 49.58 6.22
Price to Book (MRQ) 3.12 10.17 5.20
Price to Tangible Book (MRQ) 3.12 13.83 6.74
Price to Cash Flow (TTM) 137.44 52.85 24.17
% Owned Institutions 86.67 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) 0.00 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago -- 47.89 6.50
Sales - 5 Yr. Growth Rate -- 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago 55.85 75.90 23.09
EPS (TTM) vs TTM 1 Yr. Ago 100.03 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 3.54 3.44 3.10
LT Debt to Equity (MRQ) 0.00 18.69 11.49
Total Debt to Equity (MRQ) 0.00 31.36 16.03
Interest Coverage (TTM) -- -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) 11.77 -- --
EBITD - 5 Yr. Avg -- -110.03 13.16
Operating Margin (TTM) 7.10 -185.03 6.07
Operating Margin - 5 Yr. Avg. -- -126.47 8.47
Pre-Tax Margin (TTM) 9.83 -175.80 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.63 8.71
Net Profit Margin (TTM) 8.41 -182.53 3.12
Net Profit Margin - 5 Yr. Avg. -- -137.03 4.91
Effective Tax Rate (TTM) 14.44 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 915,000 7,648,872 873,051,409
Net Income/Employee (TTM) 76,953 653,324 103,483,755
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.43 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 3.58 6.47 11.45
Return on Assets - 5 Yr. Avg. -- 5.54 12.50
Return on Investment (TTM) 4.65 9.01 14.96
Return on Investment - 5 Yr. Avg. -- 6.87 16.23
Return on Equity (TTM) 0.82 10.15 16.52
Return on Equity - 5 Yr. Avg. -- 8.40 17.37
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 36.71 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Jounce Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 13.73 9.81 99 98
13 Week 20.24 14.38 99 94
26 Week -23.39 -29.21 53 98
52 Week -- -- -- 68
YTD -- -- -- 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 77.39%
# of Holders: 125
Total Shares Held: 25,306,659
3 Mo. Net Change: -986,829
# New Positions: 21
# Closed Positions: 19
# Increased Positions: 58
# Reduced Positions: 44
# Net Buyers: 14
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.